alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.1





Certification of CEO and CFO

Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002







In connection with the Quarterly Report on Form 10-QSB of Oxford Residential Properties I Limited Partnership (the "Partnership"), for the quarterly period ended September 30, 2007 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Martha L. Long, as the equivalent of the chief executive officer of the Partnership, and Stephen B. Waters, as the equivalent of the chief financial officer of the Partnership, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:



(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Partnership.





| |                        
| | -----------------------
| | /s/Martha L. Long      
| | Name: Martha L. Long   
| | Date: November 13, 2007
| |                        
| | /s/Stephen B. Waters   
| | Name: Stephen B. Waters
| | Date: November 13, 2007





This certification is furnished with this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Partnership for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
<TABLE> <S> <C>

<ARTICLE> 9
<MULTIPLIER> 1000
       
<S>                                       <C>
<PERIOD-TYPE>                              YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                          14,406
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                 3,500
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                     62,856
<INVESTMENTS-CARRYING>                          42,420
<INVESTMENTS-MARKET>                            43,430
<LOANS>                                        291,070
<ALLOWANCE>                                      4,291
<TOTAL-ASSETS>                                 428,174
<DEPOSITS>                                     352,545
<SHORT-TERM>                                     9,952
<LIABILITIES-OTHER>                              2,962
<LONG-TERM>                                     22,502
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        16,619
<OTHER-SE>                                      23,594
<TOTAL-LIABILITIES-AND-EQUITY>                 428,174
<INTEREST-LOAN>                                 26,754
<INTEREST-INVEST>                                6,016
<INTEREST-OTHER>                                   344
<INTEREST-TOTAL>                                33,114
<INTEREST-DEPOSIT>                              15,041
<INTEREST-EXPENSE>                              16,764
<INTEREST-INCOME-NET>                           16,350
<LOAN-LOSSES>                                      550
<SECURITIES-GAINS>                                (19)
<EXPENSE-OTHER>                                 11,602
<INCOME-PRETAX>                                  6,489
<INCOME-PRE-EXTRAORDINARY>                       6,489
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     5,165
<EPS-PRIMARY>                                     1.60
<EPS-DILUTED>                                     1.60
<YIELD-ACTUAL>                                    4.59
<LOANS-NON>                                        893
<LOANS-PAST>                                       196
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                 4,179
<CHARGE-OFFS>                                      628
<RECOVERIES>                                       190
<ALLOWANCE-CLOSE>                                4,291
<ALLOWANCE-DOMESTIC>                             3,508
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                            783
        

</TABLE>
II

106TH CONGRESS

2D SESSION S. 2558

To amend the Taxpayer Relief Act of 1997 to provide for consistent treatment

of survivor benefits for public safety officers killed in the line of duty.

IN THE SENATE OF THE UNITED STATES

MAY 16, 2000

Mr. BIDEN introduced the following bill; which was read twice and referred

to the Committee on Finance

A BILL

To amend the Taxpayer Relief Act of 1997 to provide for

consistent treatment of survivor benefits for public safety

officers killed in the line of duty.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. CONSISTENT TREATMENT OF SURVIVOR BENE4 FITS FOR PUBLIC SAFETY OFFICERS KILLED

5 IN THE LINE OF DUTY.

6 Section 1528(b) of the Taxpayer Relief Act of 1997

7 (Public Law 105–34) is amended by striking the period

8 and inserting ‘‘, and to amounts received in taxable years
2

•S 2558 IS

1 beginning after December 31, 1999, with respect to indi2 viduals dying on or before December 31, 1996.’’.

Æ
EXHIBIT A-4

#L888721

Case: 19-30088 Doc# 1640-4 Filed: 04/24/19 Entered: 04/24/19 09:01:34 Page 1

of 5
Case: 19-30088 Doc# 1640-4 Filed: 04/24/19 Entered: 04/24/19 09:01:34 Page 2

of 5
Case: 19-30088 Doc# 1640-4 Filed: 04/24/19 Entered: 04/24/19 09:01:34 Page 3

of 5
Case: 19-30088 Doc# 1640-4 Filed: 04/24/19 Entered: 04/24/19 09:01:34 Page 4

of 5
Case: 19-30088 Doc# 1640-4 Filed: 04/24/19 Entered: 04/24/19 09:01:34 Page 5

of 5
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 9
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          SEP-30-1996
<PERIOD-START>                             OCT-01-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                             733
<INT-BEARING-DEPOSITS>                           1,724
<FED-FUNDS-SOLD>                                 3,211
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                      7,602
<INVESTMENTS-CARRYING>                          23,972
<INVESTMENTS-MARKET>                            23,521
<LOANS>                                         35,629
<ALLOWANCE>                                        382
<TOTAL-ASSETS>                                  74,401
<DEPOSITS>                                      64,335
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                              1,123
<LONG-TERM>                                        699
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           208  
<OTHER-SE>                                       8,036
<TOTAL-LIABILITIES-AND-EQUITY>                  74,401
<INTEREST-LOAN>                                  3,057
<INTEREST-INVEST>                                2,167
<INTEREST-OTHER>                                   435
<INTEREST-TOTAL>                                 5,659
<INTEREST-DEPOSIT>                               2,816
<INTEREST-EXPENSE>                                  46
<INTEREST-INCOME-NET>                            2,797
<LOAN-LOSSES>                                       57
<SECURITIES-GAINS>                                  33
<EXPENSE-OTHER>                                  2,092
<INCOME-PRETAX>                                  1,093
<INCOME-PRE-EXTRAORDINARY>                       1,093
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       386
<EPS-PRIMARY>                                     2.76
<EPS-DILUTED>                                        0
<YIELD-ACTUAL>                                    3.63
<LOANS-NON>                                         18
<LOANS-PAST>                                       205
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                   352
<CHARGE-OFFS>                                       37
<RECOVERIES>                                        10
<ALLOWANCE-CLOSE>                                  382
<ALLOWANCE-DOMESTIC>                               382
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        


</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

      ( print page 29357)    
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Center on Minority Health and Health Disparities Special NCMHD Health Disparities Research on Minority and Underserved Population (R01).                    

*Date:*                         June 16-18, 2010.                    

*Time:*                         5:30 p.m. to 2 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Embassy Suites at the Chevy Chase Pavillion, 4300 Military Road, NW., Washington, DC 20015.                    

*Contact Person:*                         Prabha L. Atreya, PhD, Chief, Office of Scientific Review, National Center on Minority Health and Health Disparities, 6707 Democracy Boulevard, Suite 800, Bethesda, MD 20892. (301) 594-8696,                         *atreyapr@mail.nih.gov.*

Dated: May 19, 2010.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-12543 Filed 5-24-10; 8:45 am]

BILLING CODE 4140-01-P
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 96-7688
UNITED STATES OF AMERICA, Plaintiff - Appellee, versus PAUL MORRIS PINSON, Defendant - Appellant. Appeal from the United States District Court for the District of South Carolina, at Greenville. William B. Traxler, Jr., District Judge; William M. Catoe, Jr., Magistrate Judge. (CR-94-720, CA-96- 1431-21-6-21AK) Submitted: July 24, 1997 Decided: July 31, 1997 Before HAMILTON, LUTTIG, and MOTZ, Circuit Judges. Dismissed by unpublished per curiam opinion. Paul Morris Pinson, Appellant Pro Se. David Calhoun Stephens, Assistant United States Attorney, Greenville, South Carolina, for Appellee. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM: Appellant seeks to appeal the district court's order denying his motion filed under 28 U.S.C.A. § 2255 (West 1994 & Supp. 1997).We have reviewed the record and the district court's opinion accepting the recommendation of the magistrate judge and denyingAppellant's § 2255 motion, and we find no reversible error. Accordingly, we deny a certificate of appealability and dismiss the appeal on the reasoning of the district court. Un ited States v. Pinson , Nos. CR-94-720; CA-96-1431-21-6-21AK (D.S.C. Oct. 9, 1996).We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

DISMISSED
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S FINANCIAL STATEMENTS INCLUDED IN THIS ANNUAL REPORT AND IS QUALIFIED
IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                          36,091
<SECURITIES>                                    15,580
<RECEIVABLES>                                   13,318
<ALLOWANCES>                                     1,429
<INVENTORY>                                          0
<CURRENT-ASSETS>                                65,503
<PP&E>                                           5,401
<DEPRECIATION>                                   2,275
<TOTAL-ASSETS>                                  76,286
<CURRENT-LIABILITIES>                           11,932
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           137
<OTHER-SE>                                      64,216
<TOTAL-LIABILITY-AND-EQUITY>                    76,286
<SALES>                                         26,407
<TOTAL-REVENUES>                                26,407
<CGS>                                                0
<TOTAL-COSTS>                                    7,020
<OTHER-EXPENSES>                                 6,494
<LOSS-PROVISION>                                 1,010
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                    887
<INCOME-TAX>                                       414
<INCOME-CONTINUING>                                473
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       473
<EPS-PRIMARY>                                      .04
<EPS-DILUTED>                                      .04


</TABLE>
1

UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF COLUMBIA

GARY V. JENKINS,

 Plaintiff,

v.

BLUE CROSS AND BLUE SHIELD OF 

RHODE ISLAND, et al.,

Defendants.

Civil Action No. 22-3660 (CKK)

MEMORANDUM OPINION AND ORDER

(December 9, 2022)

This matter is before the Court on consideration of Plaintiff’s pro se [1] Complaint, 

comprising just three sentences. Plaintiff, a citizen of Georgia, appears to allege that a health 

insurance company and a pharmacy, both purportedly citizens of Rhode Island, “withheld”

“healthcare services” due under a policy purportedly applicable to Plaintiff. ECF No. 1. 

Plaintiff summarily claims a violation of the Fourteenth Amendment to the Constitution and 

claims $500,000,000.00 of damages. As an initial matter, “Plaintiff [] has failed to set forth a 

basis for this [C]ourt’s subject matter jurisdiction or venue.” Mem. Op. at 2, ECF No. 3, Reyna 

v. Wisconsin, 22-3231 (UNA) (D.D.C. Nov. 28, 2022) (JEB) (slip op.) (dismissing complaint sua 

sponte on Rule 8 grounds). It is entirely unclear how the United States District Court for the 

District of Columbia has jurisdiction or venue over a matter between a citizen of Georgia and 

citizens of Rhode Island. Moreover, Plaintiff’s laconic complaint does not provide, pursuant to 

Federal Rule of Civil Procedure 8(a), “(1) a short and plain statement of the grounds for the 

court’s jurisdiction [and] (2) a short and plain statement of the claim showing that the pleader is 

entitled to relief.” See also Ciralsky v. CIA, 355 F.3d 661, 668-71 (D.C. Cir. 2004). 

As such, it is hereby,
2

ORDERED, that the [1] Complaint and this case are DISMISSED. 

SO ORDERED.

This is a final appealable order. 

Dated: December 9, 2022

 __/s/_____________________ 

COLLEEN KOLLAR-KOTELLY

United States District Judge
#### Arthur T. Mott et al., Appellants, v Incorporated Village of Hempstead, Respondent.

Submitted September 11,1995;

decided November 30, 1995

Motion to dismiss appeal granted and appeal dismissed, with $400 costs and $100 costs of motion upon the ground that it was not timely taken *(see,*CPLR 5513 [a]). Appellants failed to timely file the notice of appeal in the office where the judgment or order of the court of original instance is entered *(see,*CPLR 5515 [1]).
[Federal Register Volume 75, Number 99 (Monday, May 24, 2010)]
[Notices]
[Page 28810]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-12446]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable materials, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel; LPR.
    Date: May 28, 2010.
    Time: 9 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Room 3AN12B, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Helen R. Sunshine, PhD, Chief, Office of 
Scientific Review, National Institute of General Medical Sciences, 
National Institutes of Health, Natcher Building, Room 3AN-12F, 
Bethesda, MD 20892, (301) 594-2881, <a href="/cdn-cgi/l/email-protection#8bf8fee5f8e3e2e5e3cbe5e2ece6f8a5e5e2e3a5ece4fd"><span class="__cf_email__" data-cfemail="c0b3b5aeb3a8a9aea880aea9a7adb3eeaea9a8eea7afb6">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.375, 
Minority Biomedical Research Support; 93.821, Cell Biology and 
Biophysics Research; 93.859, Pharmacology, Physiology, and 
Biological Chemistry Research; 93.862, Genetics and Developmental 
Biology Research; 93.88, Minority Access to Research Careers; 93.96, 
Special Minority Initiatives, National Institutes of Health, HHS)

    Dated: May 18, 2010.
Ann Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-12446 Filed 5-21-10; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
#### JOHN SKELTON, Respondent, *v.*SARAH A. SCOTT, Appellant, Impleaded with others.

*Mortgage given by an executor*— it *is unnecessary to allege Ids appointment in an action to foreclose it.*

Where upon the conveyance of land to an executor, as such, he gives hack a purchase-money mortgage, as executor, he and his grantees are estopped from denying his appointment and authority, and it is unnecessary to allege in an action to foreclose the mortgage the time and manner of his appointment.

Appeal from an interlocutory judgment, overruling a demurrer to the complaint, interposed thereto on the ground that it did not state facts sufficient to constitute a cause of action.

This action was brought to foreclose a mortgage. The complaint alleged that said mortgage was given by one Israel O. .Beattie, as executor of the last will and testament of John J. Scott, deceased, on certain real estate situate in the village of Middletown. That said mortgage was transferred and assigned to the plaintiff. That the mortgaged premises, through certain *mesne*conveyances, came into the possession of the defendant Scott. The defendant Scott demurred to said complant, on the ground that it did not state facts sufficient to constitute a cause of action.

*Winfield, Leeds <& Morse,*for the appellant.

*Allison &*O'Neill, for the respondent.

Gilbert, J.:

The objection made by the defendant Scott that the complaint does not allege the facts relative to the appointment of Israel O. Beattie as executor, namely, when, where, and by what functionary letters testamentary were issued to him is not tenable.

Had the mortgage declared on, been made by Israel O. Beattie’s testator, these averments might have been necessary. But such was not the case.

It was made after the death of the testator by Beattie, *as*executor, and it was, therefore, unnecessary for plaintiff, as the' *376holder of it, to make the formal allegations respecting the executor’s appointment.

The proceedings by which the executor was appointed, and the transfer of the testator’s effects, under these proceedings, would not be a necessary part of the plaintiff’s proof upon the trial, and hence the averment of them would be unnecessary and superfluous. *(White*v. Joy, 3 Kern., 87.)

Beattie having taken a deed of the mortgaged premises in his capacity as executor, and having given back the purchase-money and mortgage in suit, expressly in that capacity, is as well as defendant Scott who holds her title under him, bound by his act and estopped to deny his appointment and authority. *(Tefft*v. Munson, 57 N. Y., 97; *Jackson*v. *Parkhurst,*9 Wend., 209.)

The order of the Special Term, overruling the demurrer of the defendant Scott, must be affirmed, with costs.

Present — Barnard, P. J., and Gilbert, J.; Dyeman, J., not sitting.

Judgment affirmed, with costs.